BCL2 and cancer: Both in vitro and in vivo studies have shown that elevated Bcl-2 level in cancer cells under hypoxia condition induces VEGF expression, enhances its mRNA stability, promotes its secretion and its transcriptional activity, resulting in increased vascularization that is independent of cell survival [24,27].